As of June 30, HCA had roughly $27 billion of outstanding debt. HCA also had $518 million of cash on hand and 4.2x total debt-to-EBITDA. For the rest of 2012 and going into 2013, HCA has “some sizeable near-term maturities in the capital structure,” according to Fitch’s report. This includes $1.5 billion of unsecured notes and $1.7 billion of bank term loan maturities.
Overall, Fitch analysts believe HCA has the financial wherewithal to deal with the short-term debt obligations, as HCA is still producing high volumes of cash. In addition, if HCA is able to maintain its total debt-to-EBITDA ratio below 4.5x over the next 12 to 18 months, Fitch could consider a positive rating action.
More Articles on HCA:
For-Profit, Non-Profit Dispute Over Florida Trauma Centers Unfolds in Appeals Court
9 Major For-Profit Hospital Operators Release Quarterly Earnings
HCA Faces More Scrutiny — This Time Over ED Care
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
